BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36708803)

  • 1. Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases.
    Cattoni A; Capitoli G; Casagranda S; Corti P; Adavastro M; Molinaro A; Di Gennaro F; Bonanomi S; Biondi A; Galimberti S; Balduzzi A
    Transplant Cell Ther; 2023 Apr; 29(4):271.e1-271.e12. PubMed ID: 36708803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
    Inati A; Kahale M; Sbeiti N; Cappellini MD; Taher AT; Koussa S; Nasr TA; Musallam KM; Abbas HA; Porter JB
    Pediatr Blood Cancer; 2017 Jan; 64(1):188-196. PubMed ID: 27576370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron Overload in Survivors of Childhood Cancer.
    Schempp A; Lee J; Kearney S; Mulrooney DA; Smith AR
    J Pediatr Hematol Oncol; 2016 Jan; 38(1):27-31. PubMed ID: 26422286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
    Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
    Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
    Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
    Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of iron overload in hematopoietic stem cell transplantation.
    Wang C; Zhao M; Liu Q; Yang Y; Li Y; Nie Y; Gao S; Li W
    Transpl Immunol; 2023 Jun; 78():101820. PubMed ID: 36921731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Iron Overload and Iron Chelation with Deferasirox on Outcomes of Patients with Severe Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Pan T; Ji Y; Liu H; Tang B; Song K; Wan X; Yao W; Sun G; Wang J; Sun Z
    Transplant Cell Ther; 2023 Aug; 29(8):507.e1-507.e8. PubMed ID: 37116582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Evaluation of Relationship Between Iron Overload and Transplantation Complications in Pediatric Patient Who Underwent Allogeneic Stem Cell Transplantation Due to Acute Leukemia and Myelodysplastic Syndrome.
    Küpesiz FT; Hazar V; Eker N; Guler E; Yesilipek MA; Tuysuz G; Kupesiz A
    J Pediatr Hematol Oncol; 2020 Jul; 42(5):e315-e320. PubMed ID: 32427707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
    Majhail NS; DeFor T; Lazarus HM; Burns LJ
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.
    Chotsampancharoen T; Gan K; Kasow KA; Barfield RC; Hale GA; Leung W
    Pediatr Transplant; 2009 May; 13(3):348-52. PubMed ID: 18518909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A magnetic resonance imaging study of iron overload in hemopoietic stem cell transplant recipients with increased ferritin levels.
    Au WY; Lam WM; Chu WC; Tam S; Wong WK; Pennell DJ; Lie AK; Liang R
    Transplant Proc; 2007 Dec; 39(10):3369-74. PubMed ID: 18089387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.
    Sivgin S; Baldane S; Kaynar L; Kurnaz F; Pala C; Ozturk A; Cetin M; Unal A; Eser B
    Neoplasma; 2012; 59(2):183-90. PubMed ID: 22248276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia.
    Ngim CF; Lee MY; Othman N; Lim SM; Ng CS; Ramadas A
    Hemoglobin; 2019 Mar; 43(2):95-100. PubMed ID: 31179787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of hepatic T2* MRI values and serum ferritin concentration in predicting thalassemia major classification for hematopoietic stem cell transplantation.
    Hamidieh AA; Moeininia F; Tayebi S; Shamshiri AR; Behfar M; Jalili M; Alimoghaddam K; Ghavamzadeh A
    Pediatr Transplant; 2015 May; 19(3):301-6. PubMed ID: 25582244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
    Pipaliya N; Solanke D; Parikh P; Ingle M; Sharma R; Sharma S; Sawant P
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.
    Armand P; Kim HT; Rhodes J; Sainvil MM; Cutler C; Ho VT; Koreth J; Alyea EP; Hearsey D; Neufeld EJ; Fleming MD; Steen H; Anderson D; Kwong RY; Soiffer RJ; Antin JH
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):852-60. PubMed ID: 20854920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation.
    Brissot E; Savani BN; Mohty M
    Semin Hematol; 2012 Jan; 49(1):35-42. PubMed ID: 22221783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2(∗) MRI changes in the heart and liver of ex-thalassemic patients after hematopoietic stem cell transplantation.
    Hamidieh AA; Tayebi S; Moeininia F; Shamshiri AR; Behfar M; Alimoghaddam K; Ghavamzadeh A
    Hematol Oncol Stem Cell Ther; 2014 Sep; 7(3):103-8. PubMed ID: 24998835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.